At-risk opioid users in a managed care insured population: Identification and outreach from a medical and pharmacy claims database
DOI:
https://doi.org/10.5055/jom.0881Keywords:
opioid use patterns, opioid use disorder, managed careAbstract
Objective: To deploy an algorithm using medical and pharmacy claims data to identify members of a managed care organization at risk for opioid misuse and provide outreach.
Methods: A retrospective review of 2019 enrollment information and prescription and medical claims data identified members aged 18-64 years with medical and pharmacy benefits and at least one paid pharmacy claim for an opioid. The most recent paid prescription claim served as the index date for each patient. Members with cancer or sickle cell disorder, receiving palliative/hospice care, or nursing home residents were excluded. Diagnoses were obtained for 12 months prior to the index date, while medication use was assessed within 6 months prior to the index date. Clinical characteristics were used to stratify members by risk of opioid misuse into risk-based cohorts.
Results: There were 62,986 adult members with medical and pharmacy benefits receiving at least one scheduled (II, III, or IV) opioid during 2019. In this group, the average age was 43.3 years (±13.0), with 56 percent being female. More frequent diagnoses included low back pain (13.2 percent) and anxiety disorder (12.4 percent). About 10.3 percent of the group (n = 6,486 members) were assigned to one or more at-risk cohorts. Out of a total outreach attempt for 804 members, 45 percent had successful engagement. Of those members engaged, 39.8 percent declined any support services offered.
Conclusion: An evidence-based algorithm found 10.3 percent of members at higher risk of opioid misuse. Interventions for targeted members reached fewer than half, and many declined assistance. Health plans need more effective intervention strategies.
References
Centers for Disease Control and Prevention: Understanding the opioid overdose epidemic. Available at https://www.cdc.gov/opioids/basics/epidemic.html. Accessed November 19, 2023.
Cragg A, Hau JP, Woo SA, et al.: Risk factors for misuse of prescribed opioids: A systematic review and meta-analysis. Ann Emerg Med. 2019; 74(5): 634-646.
Kaye AD, Jones MR, Kaye AM, et al.: Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1. Pain Phys. 2017; 2(2S): S93-S109.
Ali MM, Tehrani AB, Mutter R, et al.: Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and Medicaid. Addict Behav. 2019; 98: 106016.
Sullivan MD, Edlund MJ, Fan MY, et al.: Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: The TROUP study. Pain. 2010; 150(2): 332-339.
Argoff CE, Kahan M, Sellers EM: Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence. J Opioid Manag. 2014; 10(2): 119-134.
Edlund MJ, Martin BC, Fan MY, et al.: Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study. Drug Alcohol Depend. 2010; 112(1-2): 90-98.
Edlund MJ, Steffick D, Hudson T, et al.: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007; 129(3): 355-362.
Starrels JL, Becker WC, Weiner MG, et al.: Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011; 26(9): 958-964.
Raman SR, Bush C, Karmali RN, et al.: Characteristics of new opioid use among Medicare beneficiaries: Identifying high-risk patterns. J Manag Care Spec Pharm. 2019; 25(9): 966-972.
Campbell CI, Bahorik AL, VanVeldhuisen P, et al.: Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018; 110: 31-37.
Rough K, Huybrechts KF, Hernandez-Diaz S, et al.: Using prescription claims to detect aberrant behaviors with opioids: Comparison and validation of 5 algorithms. Pharmacoepidemiol Drug. 2019; 28(1): 62-69.

Published
How to Cite
Issue
Section
License
Copyright 2005-2025, Weston Medical Publishing, LLC and Journal of Opioid Management. All Rights Reserved.